ITGB8 and squamous cell lung carcinoma: In lung squamous cell carcinoma, it promotes proliferation, migration, and tumor progression by modulating the expression of Bcl-2 and Bax [32], enhancing ITGB8 expression [30], and binding to miR-299-3p, resulting in elevated MAP3K2 expression [31].